VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1684382
Sex: M
Age:
State: TX

Vax Date: 03/15/2021
Onset Date: 05/01/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: got a lump at the injection site, left arm; itching a lot; he doesn't know if it's related or not, but something stung him on his thumb.; This is a spontaneous report from a contactable consumer. A 55-years-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 15Mar2021 12:15 (Batch/Lot Number: 6204) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history included ongoing diabetes mellitus, bronchiectasis from an unknown date and unknown if ongoing. Concomitant medication included metformin (METFORMIN) taken for diabetes mellitus, start and stop date were not reported; risperidone (RISPERIDONE) taken for affective disorder, start and stop date were not reported; colecalciferol (VITAMIN D3) taken for asthenia, start and stop date were not reported; cyanocobalamin, folic acid (VITAMIN B12 & FOLIC ACID) taken for asthenia, start and stop date were not reported. The patient experienced itching a lot on 07May2021, got a lump at the injection site, left arm on 09May2021, he doesn't know if it's related or not, but something stung him on his thumb on May2021. The outcome of the event itching a lot and got a lump at the injection site, left arm was not recovered and outcome of the event something stung him on his thumb was unknown. Additional Context: Caller stated that he's got a lump at the injection site of the Pfizer vaccine. Caller verifies it was the Pfizer Covid Vaccine. Caller states it itches a lot too. Pfizer Covid Vaccine: First Dose he received the first one 22Feb2021. Caller provided LOT: EN6201. Caller unsure of Expiry date, NDC. Caller states received as injection in left arm. Caller received between 12 and 2pm, he doesn't really remember. Caller states he had the appointment at 10 and had to stand in line for hours to get it. Pfizer Covid Vaccine: Second Dose: Caller states he received the second dose 15Mar2021. Caller states on the card, they just wrote Pfizer scribble, the two letters are indecipherable. Caller states all it says is Pfizer 6204 and the rest is just scribbled. Caller verifies it is handwritten. Caller states no expiry date or NDC on card. Caller states received second dose at 1215pm in his left arm. Address: Caller states he must get permission from his phone to look it up. Caller states he moved so he doesn't know it yet. Caller states he doesn't live at a permanent address but can give his parents address if Pfizer needs that. Itching; lump: Caller states he started itching about 3 days ago and now it's a lump because he was scratching it. Prescribing Healthcare Professional: Caller states he doesn't have a primary care doctor, he is just starting a new job. Caller states he doesn't know if it's related or not, but something stung him on his thumb. Caller states it was like an ant bite, but serious. Caller states at first, he thought it was a brown recluse, it was the same arm, on his left thumb. Caller states it turns out it was just an ant. No follow up attempt is needed: No further information is expected.

Other Meds: METFORMIN; RISPERIDONE; VITAMIN D3; VITAMIN B12 & FOLIC ACID

Current Illness: Diabetes (Verbatim: diabetes)

ID: 1684383
Sex: F
Age:
State:

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: her arm(site of Covid vaccine)was itching; raised blisters and welps over her upper arm near the vaccine injection site; raised blisters and welps over her upper arm near the vaccine injection site; This is a spontaneous report from a contactable consumer, based on information received by Pfizer from Amgen. This non-serious solicited report was reported to Amgen on 21/APR/2021 by a consumer from a commercial program. A 59-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration, administrated in arm on 01Apr2021 (age at the time of vaccination 59-years-old), as a single dose for COVID-19 immunization. The patient's medical history included Rheumatoid arthritis. The patient's concomitant medications included Etanercept (Enbrel) 50 mg weekly, from 01Mar2021 to 07Apr2021, for Rheumatoid arthritis. On an unspecified date Apr2021, the patient experienced her arm (site of COVID-19 Vaccine) was itching, and raised blisters and welps over her upper arm near the vaccine injection site. Treatment for the event injection site urticaria included Benadryl (diphenhydramine hydrochloride), Tylenol (paracetamol). Caller stated, on 01/MAR/2021, the patient took her first dose of Enbrel and noticed no reaction and was fine; second dose was also fine. On an unknown date in MAR/2021, the patient took her third dose of Enbrel and four days after the injection she developed a large, red welp five inch in diameter on her thigh. On an unknown date in 2021, the patient took fifth dose of Enbrel and the patient's reactions were coming sooner, this time within in two days and same giant welp. The outcome for all the events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds: ENBREL

Current Illness: Rheumatoid arthritis

ID: 1684384
Sex: F
Age:
State: NM

Vax Date: 05/07/2021
Onset Date: 05/01/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: lost my appetite for food; Pain in left arm at the injection site; I began to feel very dizzy, fatigued and nauceous like my equilibrium was off; I began to feel very dizzy, fatigued and nauceous like my equilibrium was off; I began to feel very dizzy, fatigued and nauceous like my equilibrium was off; I began to feel very dizzy, fatigued and nauceous like my equilibrium was off; I will have hot sweats; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07May2021 at 12:00 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. Medical history included allergic to a lot of plants, allergy to grass, latex and trees. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine (MANUFACTURER UNKNOWN) and fluticasone propionate (FLONASE); both for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously took silicones nos (MANUFACTURER UNKNOWN) (reported as silicone) for unspecified indication from unknown date and experienced drug allergy on unknown date. On 07May2021 at 15:00, after the first dose of the Pfizer vaccine, the patient experienced pain in left arm at the injection site. The patient began to feel very dizzy, fatigued and nauseous like equilibrium was off. On 11May2021, the patient still felt dizzy, fatigued, nauseous and the patient had lost appetite for food and sometimes patient had hot sweats but patient did not have a fever. The current day (this was day 4), the patient 's arm was no longer sore, but still felt fatigue, dizziness and nauseous. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event pain in left arm at the injection site was recovered on an unknown date in May2021. The clinical outcome of the events felt very dizzy, fatigued, nauseous, equilibrium was off, lost appetite and hot sweats was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: CETIRIZINE; FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1684385
Sex: F
Age:
State: NJ

Vax Date: 04/24/2021
Onset Date: 04/25/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data: Test Date: 20210425; Test Name: Pulse rate; Result Unstructured Data: Test Result:50/85; Comments: Low pulse ca 50/85; Test Date: 20210425; Test Name: Pulse rate; Result Unstructured Data: Test Result:90; Comments: Around 90 resting; Test Date: 20210425; Test Name: Pulse rate; Result Unstructured Data: Test Result:190; Comments: High pulse 190 upon marginal exercise

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 24Apr2021 at 11:45 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included systemic lupus erythematosus (SLE). The patient previously took cephalexin (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 03Apr2021 at 11:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. On 25Apr2021 at 08:00, the patient experienced high pulse 190 upon marginal exercise, around 90 resting and low pulse 50/85, lasting about 2 weeks. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On 25Apr2021, the patient underwent lab tests and procedures which included pulse rate and the results were 190 (units unspecified), 90 (units unspecified) and 50/85 (units unspecified). Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events, high pulse 190 upon marginal exercise, around 90 resting and low pulse 50/85 were recovering at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1684386
Sex: F
Age:
State: IN

Vax Date:
Onset Date: 02/01/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: COVID-19 test; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: My hair is falling out and I have alopecia now; This is a spontaneous report from a contactable healthcare professional, the patient. A 40-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on an unknown date (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Feb2021 the patient experienced hair was falling out and had alopecia. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse events (unspecified). On an unknown date, the patient underwent Sars-cov-2 test and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event hair was falling out and had alopecia was unknown at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684387
Sex: M
Age:
State: CA

Vax Date: 05/01/2021
Onset Date: 05/01/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: pain; Result Unstructured Data: Test Result:it is not 10 out of 10 pain

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: higher part of his arm and then tapered down the arm. It feels like he has been punched in the arm; arm pain and pain at the injection site.; arm pain and pain at the injection site.It is now spreading to the underside of his arm and towards his chest.; arm pain; This is a spontaneous report from a contactable consumer or other non hcp. A 48-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: not reported), dose 1 via an unspecified route of administration, administered in Arm on May2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. In May2021, the patient experienced higher part of his arm and then tapered down the arm. it feels like he has been punched in the arm, arm pain and pain at the injection site, arm pain and pain at the injection site.it is now spreading to the underside of his arm and towards his chest and arm pain. The patient underwent lab tests and procedures which included pain assessment: it is not 10 out of 10 pain. It was reported that the patient received the vaccine a week ago. He was okay for the first 2-4 days. About four and half days in, he started experiencing arm pain and pain at the injection site. It was at the higher part of his arm and then tapered down the arm. It felt like he has been punched in the arm. It is now spreading to the underside of his arm and towards his chest. It seem to be getting worse, not better. He spoke with his pharmacist and doctor who said it was not normal. The patient asked if the events were reported and if it was unusual as the events started few days later. He asked if he can take Tylenol. He reported first 3-4 days, 4.5 days in experiencing pain in arm, injection site into arm, higher side and taper to lower side and now all on underside of arm towards chest. the same arm that vaccine. Felt like he's been punched in the arm. Outcome of the events were not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1684388
Sex: F
Age:
State: SC

Vax Date: 05/05/2021
Onset Date: 05/06/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Two days later (the fifth day after the second shot), I had my first ever outbreak of shingles. The shingles occurred on the right side of my face and over my right eye; Fever blister breakout on upper lip for the first time in several years began three days after second shot; This all occurred after the second shot: chest tightness; Extreme difficulty breathing; This is a spontaneous report from a contactable consumer (patient). A 23-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/ batch number: unknown) via unspecified route of administration in Arm Left on 05May2021 12:00 PM (age at vaccination was 23 years) as dose 2, single for COVID-19 immunization. The patient's medical history included bipolar 1, anxiety and eating disorder. The patient has known allergy for codeine. Concomitant medication was not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/ batch number: unknown) via unspecified route of administration on in Left arm 14Apr2021 04:00 PM (age at vaccination was 23 years and non-pregnant at the time of vaccination) as DOSE 1, SINGLE for COVID-19 immunization. No other vaccine in four weeks. No other vaccine in two weeks. There was no COVID prior vaccination. The patient was not tested for COVID post vaccination. This all occurred after the second shot: on 06May2021, 01:00 PM, chest tightness and extreme difficulty breathing, which began within 24 hours of the shot then lasted another 24 hours. Fever blister breakout on upper lip for the first time in several years began three days after the second shot. Two days later (the fifth day after the second shot), she had her first ever outbreak of shingles. The shingles occurred on the right side of face and over her right eye. AE resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment with valacyclovir pills, steroid injection and pills for the events. The outcome of the events was recovering. No follow up attempts are possible. information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1684389
Sex: M
Age:
State: MI

Vax Date: 05/04/2021
Onset Date: 05/05/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Persistent tinnitus in both ears; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 04May2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Other medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 13Apr2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. On 05May2021, the patient experienced persistent tinnitus in both ears. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event persistent tinnitus in both ears was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684390
Sex: F
Age:
State:

Vax Date: 03/26/2021
Onset Date: 04/02/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Patient experienced sharp stabbing/throbbing pain behind her ear that lasts ~10 seconds,; Neck hurt; Pt experienced sharp stabbing/throbbing pain behind her back of head that lasts ~10 seconds, then her headhurt; This is a spontaneous report from a non-contactable pharmacist. A 38-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6200) via an intramuscular route of administration on 26Mar2021(at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, polycystic ovarian syndrome (PCOS) and asthma. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), montelukast sodium (SINGULAIR), famotidine (MANUFACTURER UNKNOWN), spironolactone (MANUFACTURER UNKNOWN) and vitamins nos (MVI) for unknown indication on unknown dates and unknown if ongoing. The patient previously took sulfamethoxazole, trimethoprim (BACTRIM) for unknown indication on unknown date and experienced hives and facial swelling. The patient previously took amoxicillin, clavulanic acid (AUGMENTIN) for unknown indication on unknown date and experienced nausea and vomiting. On 02Apr2021, after first dose of Pfizer COVID-19 vaccine administration on 26Mar2021, the patient experienced sharp stabbing/throbbing pain behind her ear/back of head that lasted for 10 seconds, then her head and neck hurt. Those events occurred similarly 5 times since the initial event. She was recommended to consult her primary care physician and had been referred to neurologist for follow-up. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the adverse events which included treatment with ASPIRIN, ibuprofen (MANUFACTURER UNKNOWN) and tizanidine (MANUFACTURER UNKNOWN). Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events sharp stabbing/throbbing pain behind ear/back of head, then head and neck hurt were unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: LEVOTHYROXINE; SINGULAIR; FAMOTIDINE; SPIRONOLACTONE; MVI [VITAMINS NOS]

Current Illness:

ID: 1684391
Sex: F
Age:
State: MA

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: Heart rate; Result Unstructured Data: Test Result:90-130; Comments: After both the shots, the patient had an elevated heart rate. About 12-15 hours after the shots it shoots up to 90-130.; Test Name: Heart rate; Result Unstructured Data: Test Result:60-80; Comments: Resting heart rate is usually between 60 and 80.

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Elevated heart rate; Elevated heart rate; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 19Apr2021 at 08:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 11May2021 at 17:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis, anxiety and formaldehyde allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received cefprozil (CEFZIL), ibuprofen (MANUFACTURER UNKNOWN) and bupropion hydrochloride (WELLBUTRIN) and experienced drug allergy. Concomitant medications included ketorolac (MANUFACTURER UNKNOWN), hyoscyamine (MANUFACTURER UNKNOWN), diazepam (VALIUM), paracetamol (TYLENOL), diphenhydramine, paracetamol, phenylpropanolamine hydrochloride (BENADRYL), etc; all for unknown indications, from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 19Apr2021 at 23:30, and on 12May2021, the patient experienced elevated heart rate after both the first and second shots. The patient reported her resting heart rate was usually between 60 and 80. About 12-15 hours after the shots, it shot up to 90-130. The first time she got the shot, it went away within a few days. The patient underwent lab test and procedures which included test for heart rate on unknown date and the result was between 60 - 80 (UNSPECIFIED UNITS) and again underwent test for heart rate after the vaccinations, on an unknown date in 2021, and the result was 90-130 (UNSPECIFIED UNITS). Since the vaccination, the patient had not been tested for COVID-19. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the reported event. The clinical outcome of the event elevated heart rate, after the first dose, was recovered on an unknown date in 2021 after the duration of few days and the clinical outcome of the event elevated heart rate, after the second dose, was recovered on an unknown date in May2021. No follow-up attempts are possible. No further information is expected

Other Meds: KETOROLAC; HYOSCYAMINE; VALIUM; TYLENOL; BENADRYL

Current Illness:

ID: 1684392
Sex: M
Age:
State: MI

Vax Date: 05/07/2021
Onset Date: 05/09/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Tiredness; Muscle pain; Chills; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07May2021 at 13:15 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 13:15 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 09May2021, the patient experienced tiredness, muscle pain and chills which had long lasting side effects; lasting up to 5 to 6 days after injection. Tiredness increased in intensity two days after injection, lasting to 5 days after injection. The events had resulted in doctors or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tiredness, muscle pain and chills was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684393
Sex: U
Age:
State:

Vax Date:
Onset Date: 05/01/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Enlarged left axillary lymph nodes; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. On an unknown date in May2021, the patient experienced enlarged left axillary lymph nodes. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was unknown if any therapeutic measures were taken as a result of the event. The clinical outcome of the event enlarged left axillary lymph nodes was unknown at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684394
Sex: F
Age:
State: MD

Vax Date: 05/07/2021
Onset Date: 05/09/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Swelling on left side of collarbone. Thought it was swollen lymph node but it is a large sized area but not overly swollen but it is noticeable.; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07May2021 at 16:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 09:00 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. On 09May2021, the patient experienced swelling on left side of collarbone. Thought it was swollen lymph node but it was a large sized area but not overly swollen but it was noticeable. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event but the patient reported that if it does not go away within that week, will seek treatment for it. The clinical outcome of the event swelling on left side of collarbone, thought it was swollen lymph node but it was a large sized area but not overly swollen but it was noticeable was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684395
Sex: M
Age:
State: SC

Vax Date: 11/10/2020
Onset Date: 11/12/2020
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: had swelling in elbows; Had swelling in ankles; Had swelling in knees; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 10Nov2020 at 09:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included rosuvastatin calcium (CRESTOR) 10 mg for unknown indication on unknown date and unknown if ongoing. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 21Oct2020 at 09:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. On 12Nov2020 at 00:00, the patient experienced swelling in ankles, elbows, and knees. The swelling in the ankles discontinued. However still have the problems with his knees and elbows. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling in ankles were recovered on an unknown date in 2021, while that of the events swelling in elbows, and knees was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: CRESTOR

Current Illness:

ID: 1684396
Sex: F
Age:
State: MI

Vax Date: 05/09/2021
Onset Date: 05/01/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Felt tired; Like she was catching a cold; This is a spontaneous report from a contactable consumer. A female patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on 09May2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. On an unknown date in May2021, the patient felt tired and like she was catching a cold. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events felt tired and like she was catching a cold was unknown at the time of the report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684397
Sex: M
Age:
State: WA

Vax Date: 05/07/2021
Onset Date: 05/08/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: felt tired and headaches; felt tired and headaches; brain fog/lack of concentration; brain fog/lack of concentration; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 07May2021 at 13:45 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to tree nut. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not take any concomitant medication. The patient previously took BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 16Apr2021 at 13:30 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. On 08May2021 at 12:15, 2 days after second shot, the patient experienced tired and headaches. That all disappeared but the patient still had brain fog/lack of concentration 5 days later. It was also reported as that no adverse reaction after first dose, the patient just wanted to report this and was really hope the brain fog goes away. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tired and headaches was recovered on an unknown date in May2021 and of the event brain fog and lack of concentration was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1684398
Sex: F
Age:
State: VT

Vax Date: 05/07/2021
Onset Date: 05/07/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Pain at injection site; Swelling at injection site; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0167) via an unspecified route of administration in the left arm on 07May2021 at 13:15 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included atenolol (MANUFACTURER UNKNOWN), duloxetine (MANUFACTURER UNKNOWN) and losartan (MANUFACTURER UNKNOWN); all taken for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 at 09:15 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. On 07May2021, the patient experienced pain and swelling at injection site which persisted for 5 days after injection. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events pain at injection site and swelling at injection site was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ATENOLOL; DULOXETINE; LOSARTAN

Current Illness:

ID: 1684399
Sex: F
Age:
State: CO

Vax Date: 04/27/2021
Onset Date: 04/27/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Fatigue; Lack of energy; Pain in left arm (vaccine arm); This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 27Apr2021 at 11:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included iron supplements (MANUFACTURER UNKNOWN) and mushroom immunity supplements (MANUFACTURER UNKNOWN); both for unknown indications from unknown dates and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PAA165969) via an unspecified route of administration in the left arm on 05Apr2021 at 11:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 27Apr2021 at 13:00, the patient experienced fatigue and lack of energy for about 24 hours after the vaccine and had pain in left arm (vaccine arm). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fatigue and lack of energy were resolved on 28Apr2021; while that of the event pain in left arm (vaccine arm) was resolved on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: IRON

Current Illness:

ID: 1684400
Sex: F
Age:
State: FL

Vax Date: 04/25/2021
Onset Date: 04/29/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: woke up to feet numb; This is a spontaneous report from a non-contactable consumer, the patient. A non-pregnant female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 25Apr2021 at 09:15 as a single dose for COVID-19 immunisation. Medical history included lung nodules and allergies to unspecified medications. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included prednisone (MANUFACTURER UNKNOWN), famotidine (MANUFACTURER UNKNOWN) and amlodipine (MANUFACTURER UNKNOWN); for an unknown indication from an unknown date and unknown if ongoing. On 29Apr2021 at 09:00, on the fourth day after first shot, the patient woke up to her feet numb. As of today, the numbness was still here. It was also reported as that the patient was due for the second dose on Sunday, 16May2021 and asking for advise if the patient should take the 2nd shot. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event woke up to feet numb was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected

Other Meds: PREDNISONE; FAMOTIDINE; AMLODIPINE

Current Illness:

ID: 1684401
Sex: F
Age:
State: NJ

Vax Date: 05/11/2021
Onset Date: 05/12/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Shakes; Vomiting; Chills; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 11May2021 at 17:15 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified birth control medication from an unknown date and unknown if ongoing. On 12May2021 at 01:30, approximately 7 hours after receiving the shot (also reported as around 01:00), the patient experienced vomiting, chills and shakes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events vomiting, chills and shakes were resolving at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1684402
Sex: M
Age:
State: NJ

Vax Date: 05/11/2021
Onset Date: 05/12/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210512; Test Name: Fever; Result Unstructured Data: Test Result:UNKNOWN

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Fever, fatigue, pain and swelling at the injection site, chest pain; Fever, fatigue, pain and swelling at the injection site, chest pain; Fever, fatigue, pain and swelling at the injection site, chest pain; Fever, fatigue, pain and swelling at the injection site, chest pain; Fever, fatigue, pain and swelling at the injection site, chest pain; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 22-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 11May2021 10:30 (at the age of 22-year-old) as dose 1, single for covid-19 immunisation. The patient medical history included none and concomitant medications were not reported. Patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was reported as other vaccine second dose was administered in left arm on 11May2021. On 12May2021, the patient experienced fever, fatigue, pain and swelling at the injection site, chest pain. The patient underwent lab tests and procedures which included body temperature: unknown on 12May2021. No treatment was taken as a result of events. The outcome of the events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1684403
Sex: M
Age:
State: CA

Vax Date: 04/18/2021
Onset Date: 04/18/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: After the second dose, same symptoms (night sweats, chills, vomiting); After the second dose, same symptoms (night sweats, chills, vomiting); After the second dose, same symptoms (night sweats, chills, vomiting), still vomiting at 4 days post-vaccine; Night Sweats, Chills, Vomiting. After first dose; Night Sweats, Chills, Vomiting. After first dose; Night Sweats, Chills, Vomiting. After first dose; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 18Apr2021 (at the age of 16-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EUU0173) via an unspecified route of administration in the left arm on 08May2021 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO) taken for an unspecified indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 19:00, after the first dose, the patient experienced night sweats, chills, vomiting and the symptoms had lasted for 4 days. On an unknown date in May2021, after the second dose, the patient experienced the same symptoms (night sweats, chills and vomiting); vomiting continued at 4 days post-vaccine. The patient was able to hydrate, but could not keep food down yet. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. Following the first dose, the clinical outcome of the events night sweats, chills and vomiting were recovered on 22Apr2021. Following the second dose, the clinical outcome of the events night sweats and chills were unknown and vomiting was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEXAPRO

Current Illness:

ID: 1684404
Sex: F
Age:
State: CA

Vax Date: 04/22/2021
Onset Date: 04/30/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: very sore arm and sensitivity; very sore arm and sensitivity; 8 days later developed chronic (ongoing) tinnitus.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 22Apr2021 at 09:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included GERD, pituitary adenoma, anxiety, migraine, tension headaches and allergy to MRI contrast. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), buspirone (MANUFACTURER UNKNOWN), famotidine (MANUFACTURER UNKNOWN) and dexlansoprazole (DEXILANT); all from unknown date for unknown indication and unknown if on going. The patient previously received codeine (MANUFACTURER UNKNOWN) and vicodin (MANUFACTURER UNKNOWN); both on unknown date for unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 08:00, the patient experienced very sore arm and sensitivity and 8 days later, developed chronic (ongoing) tinnitus, the patient was afraid to get the second shot which was scheduled for tomorrow in case it worsened it. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very sore arm and sensitivity and chronic (ongoing) tinnitus was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: GABAPENTIN; BUSPIRONE; FAMOTIDINE; DEXILANT

Current Illness:

ID: 1684405
Sex: M
Age:
State: PA

Vax Date: 04/26/2021
Onset Date: 04/26/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Electrical shocks in different areas of body; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the right arm on 26Apr2021 at 09:45 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not have allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not take any concomitant medications. On 26Apr2021 at 13:00, the patient experienced electrical shocks in different areas of body. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event electrical shocks in different areas of body was resolved on an unknown date in 2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684406
Sex: M
Age:
State: MN

Vax Date: 05/11/2021
Onset Date: 05/12/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Lymph nodes under left arm pit swollen; This is a spontaneous report from a non-contactable consumer, the patient. A 54-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 11May2021 at 08:30 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included losartan (MANUFACTURER UNKNOWN) and hydrochlorothiazide (MANUFACTURER UNKNOWN); both from unknown date for unknown indication and unknown if ongoing. The patient previously received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 20Apr2021 at 15:15 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 07:00, the patient experienced lymph nodes under left arm pit swollen. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event lymph nodes under left arm pit swollen was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: LOSARTAN; HYDROCHLOROTHIAZIDE

Current Illness:

ID: 1684407
Sex: F
Age:
State: CA

Vax Date: 02/02/2021
Onset Date: 02/04/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Swollen lymph nodes on both side of neck area close to collar bone; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 02Feb2021 at 13:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic kidney disease (CKD). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On 04Feb2021 at 09:00, the patient experienced swollen lymph nodes on both side of her neck area close to her collar bone. It was reported that swollen lymph nodes were not there prior to the vaccination. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. It was unknown whether therapeutic measures were taken as a result of the reported event. The clinical outcome of the event swollen lymph nodes on both side of neck area close to collar bone was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684408
Sex: F
Age:
State: TX

Vax Date: 05/10/2021
Onset Date: 05/11/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Inflamed skin with increased temperature on the arm around the location of the injection; Affected area is tender to the touch; Inflamed skin with increased temperature on the arm around the location of the injection; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 10May2021 at 12:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included diverticulitis, and osteoporosis and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 19Apr2021 at 12:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 11May2021 at 09:30 the patient experienced inflamed skin with increased temperature on the arm around the location of the injection and affected area was tender to the touch. The symptoms continued for three days after vaccine was administered. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events inflamed skin with increased temperature on the arm around the location of the injection and affected area was tender to the touch were not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1684409
Sex: F
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: After dose 2, I have vaginal bleeding the day after. Last period ended 8May, next period not due until 2Jun.; After dose 2, I have vaginal bleeding the day after. Last period ended 8May, next period not due until 2Jun.; This is a spontaneous report from a contactable consumer or other non hcp. A 35-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on an unspecified date as dose 2, single for covid-19 immunisation. Medical history included type 2 diabetic. Patient had Mild allergy to asparagus (facial hives). Concomitant medications included insulin glargine (LANTUS); insulin lispro (HUMALOG). Patient did not receive any other vaccines in 4 weeks. Patient did not have COVID prior vaccination. Patient did not test COVID post vaccination. Patient received previously first dose of vaccine and After dose one, her period arrived 8 days early. The patient experienced after dose 2, she has vaginal bleeding the day after. last period ended 8may, next period not due until 2jun. on an unspecified date. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: LANTUS; HUMALOG

Current Illness:

ID: 1684410
Sex: F
Age:
State: OR

Vax Date: 05/07/2021
Onset Date: 05/09/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Awoke to room spinning; Nausea with neck flexion; This is a spontaneous report from a contactable nurse, the patient. A 67-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185) via an unspecified route of administration in the left arm on 07May2021 at 12:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis and allergies to dried fruit preservatives. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient received unspecified concomitant medication. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 14Apr2021 at 12:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. On 09May2021 at 07:00, (also reported as 36 hours after dose), the patient awoke to room spinning in the morning (reported as AM) did not stop for 8 hours and the patient also experienced nausea with neck flexion and spinning. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events awoke to room spinning and nausea with neck flexion was resolved on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1684411
Sex: F
Age:
State: MI

Vax Date: 04/01/2021
Onset Date: 04/20/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Fatigue; Light headedness; Slight nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733) via an unspecified route of administration in the left arm on an unknown date in Apr2021 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included ascorbic acid (VITAMIN C) for unknown indication from unknown start date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6206) via an unspecified route of administration in the left arm on 12Mar2021 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. On 20Apr2021, 2 weeks after being fully vaccinated, the patient experienced fatigue, light headedness, and slight nausea. The patient was still experiencing these symptoms (at the time of reporting) also some days were good and she felt normal and other days not good. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fatigue, light headedness, and slight nausea were not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: VITAMIN C [ASCORBIC ACID]

Current Illness:

ID: 1684412
Sex: F
Age:
State: CO

Vax Date: 04/14/2021
Onset Date:
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Mild waves of dizziness/vertigo which is not constant.; Mild waves of dizziness/vertigo which is not constant.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 14Apr2021 at 11:00, as a single dose for COVID-19 immunisation and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the right arm on 08May2021 at 11:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included citalopram (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN); both from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced mild waves of dizziness/vertigo which was not constant. The patient experienced this with the first dose as well, but not as strong as second dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild waves of dizziness/vertigo which was not constant was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CITALOPRAM

Current Illness:

ID: 1684413
Sex: F
Age:
State: HI

Vax Date: 04/30/2021
Onset Date: 05/05/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Nausea; Headache; Fatigue; This is a spontaneous report from a contactable nurse, the patient. A 59-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via intramuscular route of administration in the left arm on 30Apr2021 at 15:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, ocular dysmetria, irritable bowel syndrome (IBS), all tapes (adhesive tape) allergy and sulfonamide allergy. Prior to the vaccination, it was unknown if the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included doxylamine succinate (UNISOM), nigella sativa (BLACK SEED OIL), ibuprofen (ADVIL), magnesium (MANUFACTURER UNKNOWN), fish oil (OMEGA 3), vitamin d nos (VIT D) and cyanocobalamin (VIT B12); all taken from an unknown date for an unknown indication and unknown if ongoing. The patient previously received cefprozil (MANUFACTURER UNKNOWN), levofloxacin (LEVAQUIN), doxycycline (MANUFACTURER UNKNOWN), angelica sinensis (DONG QUAI), cetrimonium bromide (ELASTOPLAST) and panax ginseng root (GINSENG) and experienced drug allergy. On 05May2021 at 06:00, the patient experienced nausea, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nausea, headache and fatigue was recovered on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: UNISOM [DOXYLAMINE SUCCINATE]; NIGELLA SATIVA; ADVIL [IBUPROFEN]; MAGNESIUM; OMEGA 3 [FISH OIL]; VIT D [VITAMIN D NOS]; VIT B12

Current Illness:

ID: 1684414
Sex: F
Age:
State: CA

Vax Date: 05/07/2021
Onset Date: 05/09/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Ringing in the ear after 36 hours of vaccine; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07May2021 at 15:15 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within 2 weeks of the vaccination and other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 16:15 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. On 09May2021 at 07:00, the patient experienced ringing in the ear after 36 hours of vaccine. It was reported that on Sunday the patient got up with ringing in the ear. It was unknown whether any therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ringing in the ear after 36 hours of vaccine was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1684415
Sex: F
Age:
State: FL

Vax Date:
Onset Date: 04/10/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Anxiety/panic attacks (4); Anxiety/panic attacks (4); This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient had no relevant medical history and no known allergies. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 10Apr2021, the patient experienced anxiety/panic attacks (4) since second vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events anxiety/panic attacks (4) were recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684416
Sex: M
Age:
State:

Vax Date: 05/12/2021
Onset Date: 05/12/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Severe pain from shoulder to elbow at injection site; Sever pain from shoulder to elbow at injection site.; Sever pain from shoulder to elbow at injection site.; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12May2021 at 17:45 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. On 12May2021 at 20:00, the patient experienced severe pain from shoulder to elbow at injection site. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with ibuprofen (ADVIL). The clinical outcome of the events severe pain from shoulder to elbow at injection site were not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684417
Sex: M
Age:
State:

Vax Date: 04/27/2021
Onset Date: 05/01/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Seemingly random stomach cramping every couple of days. The patient diagnosed with IBS, but usually have symptoms under control, and diet has not changed recently was not resolved at the time of this report; Seemingly random stomach cramping every couple of days. The patient diagnosed with IBS, but usually have symptoms under control, and diet has not changed recently was not resolved at the time of this report.; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 27Apr2021 at 11:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome (IBS) and ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 01May2021, the patient experienced seemingly random stomach cramping which occurred every couple of days. The patient was diagnosed with IBS, but usually her symptoms under control, and diet was not changed recently. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event seemingly random stomach cramping every couple of days. The patient diagnosed with IBS, but usually have symptoms under control, and diet has not changed recently was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness: Irritable bowel syndrome (usually patient symptoms under control, and diet has not changed recently)

ID: 1684418
Sex: F
Age:
State: MI

Vax Date: 05/10/2021
Onset Date: 05/12/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Swelling and soreness/tenderness under right arm.; Swelling and soreness/tenderness under right arm; Swelling and soreness/tenderness under right arm; Numbness in right arm (elbow to hand); This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the right arm on 10May2021 at 17:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 19Apr2021 at 04:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021, the patient experienced swelling and soreness/tenderness under by right arm and numbness in right arm (elbow to hand). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling and soreness/tenderness under by right arm and numbness in right arm (elbow to hand) was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1684419
Sex: F
Age:
State: OH

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Constant migraine every day; This is a spontaneous report from a contactable other healthcare professional, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 14:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included depression and migraine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included sertraline hydrochloride (ZOLOFT) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient experienced constant migraine every day. The migraine resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of migraine and included treatment with steroids. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event constant migraine every day was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ZOLOFT

Current Illness:

ID: 1684420
Sex: M
Age:
State: MN

Vax Date: 05/12/2021
Onset Date: 05/12/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Swelling of throat; shortness of breath; chest pain; extreme fatigue; This is a spontaneous report from a contactable consumer. A 22-year-old male patient (consumer) reported for himself that he received bnt162b2 (BNT162B2, formulation: Solution for injection, Batch/Lot Number: EW0179, expiration date not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 12May2021 13:15 (Age 22-years at the time of vaccination) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The historical vaccine included bnt162b2 (BNT162B2, Batch/Lot Number: EW0164, expiration date not reported), dose 1 (First Dose) via an unspecified route of administration, administered in Left Arm on 16Apr2021 at 03:00 PM (Age 22 years at the time of vaccination) as DOSE 1, SINGLE for covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was School or Student Health Clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. An hour after the shot, the patient developed swelling of throat and shortness of breath on 12May2021 at 2:30 PM. Now it was 4 days later, and the patient still had shortness of breath and chest pain as well as extreme fatigue that was developed on 12May2021 at 2:30 PM. The patient did not receive any treatment for the adverse events. The adverse event result in visit to an emergency room/department or urgent care (Non-serious). The outcome of the events was reported as not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1684421
Sex: F
Age:
State: NH

Vax Date: 02/01/2021
Onset Date:
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Soreness at injection site; This is a spontaneous report from a contactable consumer (patient). A 44-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL3247; Expiration date was not reported) on the left arm on 01Feb2021 (14:00) as dose 1, single, with route of administration unspecified, for COVID-19 immunization at the workplace clinic. Medical history included contrast dye allergy, and lime and cooked lemons allergy. The patient's concomitant medications were not reported. The patient previously took morphine, and had drug allergy. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. On an unspecified date in 2021, the patient had soreness at the injection site. The patient had received aspirin as treatment for the event. The outcome of the event was recovered on an unspecified date in 2021. Since the vaccination, the patient has not been tested for COVID-19. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1684422
Sex: F
Age:
State: NJ

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Metallic Taste; Soreness to arm; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in Deltoid Left on 13Jan2021 03:30, at the age of 50-years-old, (Lot Number: EK9231) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included Sjogren's syndrome from 20Oct2014 and ongoing, gallbladder abscess (gallbladder removed) in 1997. Historical vaccine includes dose 1 of BNT162B2 received on 23Dec2020, 03:30, (at the age of 49-years) Intramuscular on Left Deltoid, Lot number: E49899 in which the patient experienced Metallic taste, Sore arm, malaise, chills, and nausea. Concomitant medications included hydroxychloroquine sulfate (PLAQUENIL S) taken for Sjogren's syndrome from Oct2013; colestyramine (QUESTRAN) taken for gallbladder abscess from Nov1997; and paracetamol (TYLENOL 8 HOUR) taken for an unspecified indication from 04Jan2021 14:00. On 13Jan2021 22:00, the patient experienced metallic taste and soreness to arm. The outcome of the events was recovered on 13Jan2021. No treatment was received for the events. No follow-up attempts are needed. No further information is expected.

Other Meds: PLAQUENIL S; QUESTRAN; TYLENOL 8 HOUR

Current Illness: Sjogren's syndrome

ID: 1684423
Sex: F
Age:
State: MN

Vax Date: 04/26/2021
Onset Date: 04/30/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: My menstrual cycle has been significantly different since my vaccinations. I have bled on and off for 4-5 days at a time since Pfizer shot 2.; I have bled on and off for 4-5 days at a time since Pfizer shot 2; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 35-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EW0172), via an unspecified route of administration (at the age of 35-years), administered in arm left on 26Apr2021 at 12:00 as dose 2, single for COVID-19 immunization. Medical history included premenstrual dysphoric disorder (PMDD) from an unknown date and unknown if ongoing. Concomitant medications included citalopram hydrobromide (CELEXA [CITALOPRAM HYDROBROMIDE]) taken for an unspecified indication, start and stop date were not reported. The patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: ER8732), via an unspecified route of administration (at the age of 35-years), administered in arm left on 05Apr2021 at 16:45 as dose 1, single for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 30Apr2021, since vaccination, the patient experienced my menstrual cycle has been significantly different since my vaccinations. I have bled on and off for 4-5 days at a time since Pfizer shot 2. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome for all the events was reported as not recovered. Follow-up attempts completed. No further information expected.

Other Meds: CELEXA [CITALOPRAM HYDROBROMIDE]

Current Illness:

ID: 1684424
Sex: F
Age:
State: MI

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Itching; Cramping in abdomen; Pain in hips; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in left arm on 18Feb2021 at 15:20 (Batch/Lot Number: EN6200; Expiration Date: Jun2021) (at the age of 48-years-old) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) administered in left arm (Batch/Lot Number: EL9265; Expiration date: May2021) (at the age of 48-years-old) on 28Jan2021 at 14:45 for COVID-19 immunisation and experienced chill (recovered), pain in hips (recovering) and pain in left ear (recovered); (the patient received no treatment for the events and did not require admission to the hospital). The patient experienced cramping in abdomen pain in hips on 18Feb2021 and itching on an unspecified date. The patient received no treatment for events cramping in abdomen and pain in hips and did not require admission to hospital. The events did not require an emergency room visit. The patient visited an online to use televisit for events pain in hips and itching on 18Feb2021. The outcome of event cramping in abdomen was recovered on an unspecified date; outcome of event pain in hips was not recovered; and outcome of event itching was unknown. The patient did not undergo any relevant tests. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1684425
Sex: M
Age:
State: CO

Vax Date: 05/06/2021
Onset Date: 05/20/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: MRI; Result Unstructured Data: Test Result:Unknown results; Test Date: 2021; Test Name: X-Ray; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: shingles; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 63-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot Number: OW0170) via intramuscular route of administration (Age at vaccination 63-year) in left arm on 06May2021 at 14:00 as dose 2, single for COVID-19 immunization. Patient medical history and concomitant medications were reported none. Historical vaccine included first dose of BNT162B2 (Lot no: EW0161) received via intramuscular route of administration in left arm on 13Apr2021 at 10:00 for COVID-19 immunization. Reported vaccination facility type was hospital. On 20May2021 the patient experienced shingles. AE required visit to Emergency room. The patient underwent lab tests and procedures which included magnetic resonance imaging: unknown results, x-ray: unknown results, on an unspecified date in 2021. Therapeutic measures were taken as a result of shingles, the patient was treated with Valtrex (10 days). It was reported that "the patient contracted shingles, beginning at the site of his 2nd vaccination. He stated about treatment that; he just began a course of Valtrex, the full name Valacyclovir (1 tablet three times a day, 1000 mg, Oral)." The clinical outcome of the event was resolved on an unspecified date in 2021. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1684426
Sex: F
Age:
State: CA

Vax Date: 03/28/2021
Onset Date:
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Exhaustion, hair loss, numbness in arms and feet, digestive and bowel issues, gas; Exhaustion, hair loss, numbness in arms and feet, digestive and bowel issues, gas; Exhaustion, hair loss, numbness in arms and feet, digestive and bowel issues, gas; Exhaustion, hair loss, numbness in arms and feet, digestive and bowel issues, gas; digestive and bowel issues, gas; This is a spontaneous report from a contactable Consumer. Female consumer (Patient) reported that: A 68 years old non pregnant female patient received bnt162b2 (COVID 19 Pfizer brand, Formulation: Solution for injection, lot unknown reason was Unable to locate or read the details, Expiration date: unknown) via an unspecified route of administration on 28Mar2021 12:15 as dose number unknown, single for covid-19 immunisation at Pharmacy or Drug Store (age at the vaccination 68 years old). Medical history, concomitant medications were not reported and had no known allergies. The patient had not received other vaccine in four weeks and other medications in two weeks. On an unspecified date in 2021, the patient experienced exhaustion, hair loss, numbness in arms and feet, digestive and bowel issues, gas. The patient was not Covid prior vaccination and was not tested Covid post vaccination. Adverse event resulted in doctor or other healthcare professional office/clinic visit and received treatment with Celecox1B. Outcome of events were reported as not recovered. Information on the Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1684427
Sex: F
Age:
State: IL

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: mild jointaches; muscle aches; fatigue (minor); This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Right on 11Feb2021 07:45, at the age of 70-years-old, (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. It was unknown if the patient was pregnant at the time of vaccination. The patient medical history included migraine. Concomitant medication included levothyroxine sodium (SYNTHROID) taken for an unspecified indication from 1981 and ongoing. Historical vaccine includes dose 1 of bnt162b2 for covid-19 immunisation and experienced Sore arm and fatigue on 21Jan2021 7:45 and was fine now (no treatment received); and shingrix (manufacturer: GSK No. of previous doses 1 (2 total)) on 05Jan2021 and experienced Sore arm. The patient previously took Tylenol 250 mg (1/2 tablet) on 21Jan2021 for migraine (prior vaccination). On 11Feb2021, the patient experienced mild jointaches, muscle aches, and fatigue (minor). The outcome of the events was recovered after 36hours. No treatment was received for the events. No follow-up attempts are needed, information about batch number cannot be obtained.

Other Meds: SYNTHROID

Current Illness:

ID: 1684428
Sex: M
Age:
State: CO

Vax Date: 05/24/2021
Onset Date: 05/25/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: Blood test; Result Unstructured Data: Test Result:Antibodies came back positive; Comments: Antibodies came back positive

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: He was really really tired Tuesday through Friday; This is a spontaneous report from a contactable consumer (patient) or other non-healthcare professional. A 69-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0177) as dose 1 single, administered in Deltoid Left on 24May2021 12:00 (at the age of 69-year-old) for COVID-19 immunization. Patient was diagnosed in 2011 or 2012 with antiphospholipid syndrome. The doctor that diagnosed him with Antiphospholipid syndrome earlier tested his blood, and the antibodies came back positive. He had surgery and was riding back and got a blood clot. An endocrinologist referred him and he found out he had antiphospholipid syndrome. The concomitant medications included apixaban (ELIQUIS) and testosterone (TESTOSTERONE). Because of patient condition, an auto immune disease that affects clotting, he takes Eliquis. Prior to vaccination patient did not have any vaccines within 4 weeks. The patient experienced he was really really tired on 25May2021. He was really tired Tuesday through Friday. His energy levels really came back on Saturday, 29May2021 and he felt chipper. Outcome of the vent was recovered on 28May2021. Information on Lot/Batch number was available. Additional information has been requested. Follow-up attempts are completed. No further information is expected.

Other Meds: ELIQUIS; TESTOSTERONE

Current Illness:

ID: 1684429
Sex: M
Age:
State: NY

Vax Date: 06/13/2021
Onset Date: 06/14/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: I am 15 years old, no side effects on the day of vaccination. Woke up in the middle of the night with fever and chills. Typical side effects occurred the following day (fever, fatigue, chills, headach; I am 15 years old, no side effects on the day of vaccination. Woke up in the middle of the night with fever and chills. Typical side effects occurred the following day (fever, fatigue, chills, headach; I am 15 years old, no side effects on the day of vaccination. Woke up in the middle of the night with fever and chills. Typical side effects occurred the following day (fever, fatigue, chills, headach; I am 15 years old, no side effects on the day of vaccination. Woke up in the middle of the night with fever and chills. Typical side effects occurred the following day (fever, fatigue, chills, headach; Throughout the day I experienced severe chest pain; At first I thought it may have been heartburn; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 15-years-old male patient received second dose of bnt162b2 (BNT162B2), Formulation: Solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration, administered in Arm Left on 13Jun2021 at 15:00 (at the age of 15-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Facility type of vaccine was pharmacy or Drug Store. No, other vaccine in four weeks. None of other medications in two weeks. No, covid prior vaccination, no, covid tested post vaccination. No, known allergies. No, other medical history. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 on 23May2021 for COVID-19 immunisation. It was reported that on 14Jun2021 at 04:00, the patient experienced i am 15 years old, no side effects on the day of vaccination. woke up in the middle of the night with fever and chills. typical side effects occurred the following day (fever, fatigue, chills, headache, throughout the day patient experienced severe chest pain, at first patient thought it may have been heartburn. Therapeutic measures were taken as a result of, at first patient thought it may have been heartburn. Patient was 15 years old, no side effects on the day of vaccination. Woke up in the middle of the night with fever and chills. Typical side effects occurred the following day (fever, fatigue, chills, headache, etc) however throughout the day patient experienced severe chest pain. At first patient thought it may have been heartburn but after taking tums (antacid) the chest pain was not reduced in the slightest leading me to believe it could not have been heartburn. The pain was severe and could be described as the sensation of swallowing something too large however with a more painful and long lasting feeling. No, treatment for AE. The outcome of event was recovered. Information on the Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1684430
Sex: M
Age:
State: PA

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Pain aggravated in both instances; This is a spontaneous report from a contactable consumer. This 50-year-old male consumer reported himself who received first and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via intramuscular route to left arm on Mar2021 at 13:00 and on 05Apr2021 at 13:00 as SINGLE dose for covid-19 immunization respectively and was administered at Health Clinic/Administration facility. Medical history included degenerated disc between L4/L5, episode of serious pain happened in mid-2016, post the treatment, he was ok and known allergies included IV dye and Ibuprofen. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included Amlodipine besylate 2.5mg, given for unknown indication and start date and stop date was not provided. The patient reported that post the vaccination in Mar2021 and then second dose in 05Apr2021, his pain aggravated in both instances, and he was not back to normal even as of 11Jun2021. He has been put on a regime of oral Prednisone for a week since 12Jun2021 and getting some relief in pain. Event resulted in Doctor or other healthcare professional office/clinic visit. The outcome of the event was recovering. The lot/batch number was not available despite the follow-up attempts made. Follow-up attempts completed. No further information was expected.

Other Meds: AMLODIPINE BESYLATE

Current Illness:

ID: 1684431
Sex: M
Age:
State: PA

Vax Date: 03/04/2021
Onset Date: 03/01/2021
Rec V Date: 09/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Lethargy; I can barely get through a day without feeling like I am going to fall asleep at some point; Low energy levels; This is a spontaneous report from a contactable other hcp. A 47-year-old male patient received bnt162b2 (BNT162B2), dose 1 intramuscular, administered in left arm on 04Mar2021 10:00 (Batch/Lot Number: EN6203) as Dose 1, single (at the age of 50 year) for covid-19 immunisation, dose 2 intramuscular, administered in Arm Left on 25Mar2021 03:00 (Batch/Lot Number: EL3248) as Dose 2, single for covid-19 immunisation. The patient's medical history and concomitant medications was not reported. The patient did not have covid prior vaccination, was not tested for covid post vaccination and no other vaccine in four weeks. The patient experienced lethargy, he can barely get through a day without feeling like he was going to fall asleep at some point, low energy levels (asthenia) on Mar2021. The patient did not received treatment for the events. Outcome of the events was not recovered.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am